Antibiotic consumption and its influence on the resistance in Enterobacteriaceae

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Sedláková, Miroslava Htoutou ^a   Urbánek, Karel ^b   Vojtová, Vladimíra ^a   Suchánková, Hana ^a   Imwensi, Peter ^a   Kolář, Milan ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Antibiotics; Enterobacteriaceae; Resistance; Selection pressure

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAM; QUINOLONE DERIVATIVE;

DRUG EFFECTS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYSIOLOGY; PROTEUS MIRABILIS; STATISTICAL MODEL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FLUOROQUINOLONES; HUMANS; KLEBSIELLA PNEUMONIAE; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; PROTEUS MIRABILIS;

EID: 84904274014     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-454     Document Type: Article

References (22)

1. Hospital-acquired pneumonia in ICU patients. Uvizl R, Hanulik V, Husickova V, Htoutou-Sedlakova M, Adamus M, Kolar M, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011 155 373 378
2. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW, Antimicrob Agents Chemother 2004 48 3720 3728 (Pubitemid 39304595)
3. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum beta- lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T, Antimicrob Agents Chemother 2007 51 1987 1994 (Pubitemid 46903084)
4. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y, Antimicrob Agents Chemother 2006 50 257 262
5. Prevalence of extended- -spectrum beta-lactamase-positive Klebsiella pneumoniae isolates in the Czech Republic. Kolar M, Latal T, Cermak P, Bartonikova N, Chmelarova E, Sauer P, Kesselova M, Int J Antimicrob Agents 2006 28 49 53
6. Breakpoint tables for interpretation of MICs and zone diameters. European Committee on Antimicrobial Susceptibility Testing, [ http://www.eucast.org/clinical-breakpoints
7. Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Htoutou Sedlakova M, Hanulik V, Chroma M, Hricova K, Kolar M, Latal T, Schaumann R, Rodloff AC, Med Sci Monit 2011 17 R147 BR152
8. Genetic methods for detection of antibiotic resistance: focus on extended-spectrum β-lactamases. Chroma M, Kolar M, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010 154 289 296
9. Anatomical therapeutic chemical (ATC) index (including defined daily doses (DDDs) for plain substances), WHO Collaboration Centre for Drug Statistics Methodology Oslo 1996
10. Auditing drug utilization by means of defined daily dose per bed-day. A methodological study. Bergman U, Christerson I, Jansson B, Wiholm BE, Eur J Clin Pharmacol 1980 17 183 187 (Pubitemid 10109215)
11. Antibiotic selective pressure and development of bacterial resistance. Kolar M, Urbanek K, Latal T, Int J Antimicrob Agents 2001 17 357 363 (Pubitemid 32401534)
12. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. Urbánek K, Kolář M, Lovečková Y, Strojil J, Šantavá L, J Clin Pharm Ther 2007 32 403 408 (Pubitemid 47063165)
13. The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital. Giamarellou H, Antoniadou A, Ciba Found Symp 1997 207 76 86
14. Correlation between antibiotic Use and resistance in a hospital: temporary and ward-specific observations. Willemsen I, Bogaers-Hofman D, Winters M, Kluytmans J, Infection 2009 37 432 437
15. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB, Clin Infect Dis 1997 25 230 239 (Pubitemid 127775484)
16. Haller P, Tschudin S, Dangel M, Increase of Resistant Enterobacter Isolates and Correlation With Antibiotic Consumption at the Ward Level Poster Presented in 16. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Nice. 2006 [ http://www.spitalpharmazie-basel.ch/pdf/ECCMID-Haller.pdf Accessed April 12, 2012
17. The association between antibiotic use and resistance: the role of secondary antibiotics. Bosso JA, Mauldin PD, Salgado CD, Eur J Clin Microbiol Infect Dis 2010 29 1125 1129
18. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F, Intensive Care Med 2009 35 862 870
19. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, Ramos A, Vaque-Rafart J, Bishopberger C, Hernandez Navarrete M, Calbo-Torrecillas F, Campayo J, Canton R, Estudio de Prevalencia de las Infecciones Nosocomiales en Espana (EPINE) Working Group, Euro Surveill 2011 16 40 ii=19983 [ http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19983 Accessed April 12, 2012
20. Carriage of ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tract of community subjects and hospitalized patients in the Czech Republic. Husickova V, Cekanova L, Chroma M, Htoutou-Sedlakova M, Hricova K, Kolar M, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 156 348 353
21. Analysis of enterobacteriaceae producing broad-spectrum beta-lactamases in the intensive care unit setting. Husickova V, Htoutou-Sedlakova M, Matouskova I, Chroma M, Kolar M, Open J Med Microbiol 2013 3 56 61
22. The impact of antibiotic use on resistance development and persistence. Barbosa TM, Levy SB, Drug Resist Updat 2000 3 303 311